Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model

Eur J Ophthalmol. 2020 Jul;30(4):714-722. doi: 10.1177/1120672119833271. Epub 2019 Mar 11.

Abstract

Purpose: We aimed to create mechanic optic nerve injury model in rats and investigate the neuroprotective effects of topical Coenzyme Q10 + Vitamin E (CoQ + Vit.E) molecules on retinal ganglion cells.

Methods: Mechanic optic nerve injury model was created in the right eyes of rats (n = 12). Rats were divided into two groups: glaucoma model with sham treatment and topical CoQ + Vit.E treatment. Treatment was applied for 4 weeks. Glial fibrillary acidic protein, Brn-3a antibody, and anti-Iba1 were examined by immunohistochemistry. Glial fibrillary acidic protein, Bax, Bcl-xL, and Tfam protein expression were measured by Western blot analysis.

Results: The number of Brn-3a-positive retinal ganglion cell was 15.0 ± 1.0 (min: 14, max: 16) in sham treatment group and 22.2 ± 4.8 (min: 18, max: 29) in topical CoQ10 + Vit.E treatment group. The protection of Brn-3a in CoQ10 + Vit.E was statistically significant (p < 0.05). Glial fibrillary acidic protein-positive astroglial counts were recorded as 11.7 ± 2.1 (min: 10, max: 14) in sham treatment and 2.5 ± 1.5 (min: 1, max: 4) in topical CoQ10 + Vit.E treatment group (p < 0.05). Topical CoQ10 + Vit.E treatment also decreased Iba1 expression in the retina of mechanic optic nerve injury groups. CoQ10 + Vit.E treatment prevented apoptotic cell death by increasing Bcl-xL protein expression. Also, CoQ10 + Vit.E preserved Tfam protein expression in the retina.

Conclusion: This study has shown that in glaucoma treatment the neuron protecting effect of topical CoQ10 + Vit.E molecules can be valuable.

Keywords: Rat glaucoma model; coenzyme Q10 + vitamin E; neuroprotection; retinal ganglion cell number.

MeSH terms

  • Administration, Ophthalmic
  • Animals
  • Blotting, Western
  • Calcium-Binding Proteins / metabolism
  • Disease Models, Animal
  • Drug Combinations
  • Glaucoma / drug therapy*
  • Glaucoma / metabolism
  • Glial Fibrillary Acidic Protein / metabolism
  • Immunohistochemistry
  • Male
  • Microfilament Proteins / metabolism
  • Neuroprotective Agents / therapeutic use*
  • Ophthalmic Solutions
  • Optic Nerve Injuries / drug therapy*
  • Optic Nerve Injuries / metabolism
  • Rats
  • Rats, Wistar
  • Retinal Ganglion Cells / drug effects*
  • Retinal Ganglion Cells / metabolism
  • Transcription Factor Brn-3A / metabolism
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / therapeutic use
  • Vitamin E / therapeutic use*
  • bcl-2-Associated X Protein / metabolism
  • bcl-X Protein / metabolism

Substances

  • Aif1 protein, rat
  • Bax protein, rat
  • Bcl2l1 protein, rat
  • Calcium-Binding Proteins
  • Drug Combinations
  • GFAP protein, rat
  • Glial Fibrillary Acidic Protein
  • Microfilament Proteins
  • Neuroprotective Agents
  • Ophthalmic Solutions
  • Transcription Factor Brn-3A
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Ubiquinone
  • Vitamin E
  • coenzyme Q10